Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance

PURPOSE: In cancer patients, tumor gene mutations contribute to drug resistance and treatment failure. In patients with metastatic breast cancer (MBC), these mutations increase after multiline treatment, thereby decreasing treatment efficiency. The aim of this study was to evaluate gene mutation pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhe-Yu, Xie, Ning, Tian, Can, Yang, Xiaohong, Liu, Liping, Li, Jing, Xiao, Huawu, Wu, Hui, Lu, Jun, Gao, Jianxiang, Hu, Xuming, Cao, Min, Shui, Zhengrong, Xiao, Mengjia, Tang, Yu, He, Qiongzhi, Chang, Lianpeng, Xia, Xuefeng, Yi, Xin, Liao, Qianjin, Ouyang, Quchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020712/
https://www.ncbi.nlm.nih.gov/pubmed/29807833
http://dx.doi.org/10.1016/j.ebiom.2018.05.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020712/
https://www.ncbi.nlm.nih.gov/pubmed/29807833
http://dx.doi.org/10.1016/j.ebiom.2018.05.015

Ejemplares similares